Abstract
The rapid emergence of a highly pathogenic, readily transmissible coronavirus has resulted in a global pandemic, affecting millions and destabilizing economies. This catastrophe triggered a clarion call for the immediate deployment of a protective vaccine. We describe the unique challenges of developing a vaccine against SARS-CoV-2 in a pandemic setting.
Copyright © 2020. Published by Elsevier Inc.
Publication types
- Research Support, N.I.H., Extramural
- Research Support, N.I.H., Intramural
- Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
- Animals
- Betacoronavirus / immunology*
- COVID-19
- Coronavirus Infections / epidemiology
- Coronavirus Infections / immunology*
- Coronavirus Infections / prevention & control
- Humans
- Pandemics / prevention & control*
- Pneumonia, Viral / epidemiology
- Pneumonia, Viral / immunology*
- Pneumonia, Viral / prevention & control
- SARS-CoV-2
- Time Factors
- Viral Vaccines / immunology*
- Viral Vaccines / standards
- Viral Vaccines / supply & distribution